Shigeki Yagyu

About Shigeki Yagyu

Shigeki Yagyu, With an exceptional h-index of 18 and a recent h-index of 16 (since 2020), a distinguished researcher at Kyoto Prefectural University of Medicine, specializes in the field of Cell and Gene Therapy.

His recent articles reflect a diverse array of research interests and contributions to the field:

Low blood level of tumour suppressor miR-5193 as a target of immunotherapy to PD-L1 in gastric cancer

In ovo chorioallantoic membrane assay as a xenograft model for pediatric rhabdomyosarcoma

Ligand-based, piggyBac-engineered CAR-T cells targeting EGFR are safe and effective against non-small cell lung cancers

Targeting FLT3-specific chimeric antigen receptor T cells for acute lymphoblastic leukemia with KMT2A rearrangement

303 PiggyBac transposon-mediated HER2-CAR-T cells exert anti-tumor efficacy against cholangiocarcinoma

Engineering memory-rich CAR-T cells by a piggyBac transposon system

Chimeric antigen receptor gene-modified lymphocyte having cytocidal effect

Development of anti-GD2 Antibody-producing Mesenchymal Stem Cells as Cellular Immunotherapy

Shigeki Yagyu Information

University

Position

___

Citations(all)

1643

Citations(since 2020)

873

Cited By

994

hIndex(all)

18

hIndex(since 2020)

16

i10Index(all)

32

i10Index(since 2020)

27

Email

University Profile Page

Kyoto Prefectural University of Medicine

Google Scholar

View Google Scholar Profile

Shigeki Yagyu Skills & Research Interests

Cell and Gene Therapy

Top articles of Shigeki Yagyu

Title

Journal

Author(s)

Publication Date

Low blood level of tumour suppressor miR-5193 as a target of immunotherapy to PD-L1 in gastric cancer

British Journal of Cancer

Hajime Kamiya

Shuhei Komatsu

Yusuke Takashima

Ryo Ishida

Hiroshi Arakawa

...

2024/3/9

In ovo chorioallantoic membrane assay as a xenograft model for pediatric rhabdomyosarcoma

Oncology Reports

Chika Shoji

Ken Kikuchi

Hideki Yoshida

Mitsuru Miyachi

Shigeki Yagyu

...

2023/4/1

Ligand-based, piggyBac-engineered CAR-T cells targeting EGFR are safe and effective against non-small cell lung cancers

Molecular Therapy-Oncolytics

Thanyavi Chinsuwan

Koichi Hirabayashi

Shuji Mishima

Aiko Hasegawa

Miyuki Tanaka

...

2023/12/19

Targeting FLT3-specific chimeric antigen receptor T cells for acute lymphoblastic leukemia with KMT2A rearrangement

Cancer Immunology, Immunotherapy

Masaya Suematsu

Shigeki Yagyu

Hideki Yoshida

Shinya Osone

Yozo Nakazawa

...

2023/4

303 PiggyBac transposon-mediated HER2-CAR-T cells exert anti-tumor efficacy against cholangiocarcinoma

Koichiro Shioya

Motoya Mie

Yuji Mishima

Tomio Matsumura

Yuta Ohira

...

2023/11/1

Engineering memory-rich CAR-T cells by a piggyBac transposon system

[Rinsho ketsueki] The Japanese journal of clinical hematology

Shigeki Yagyu

2023

Chimeric antigen receptor gene-modified lymphocyte having cytocidal effect

2023/9/21

Development of anti-GD2 Antibody-producing Mesenchymal Stem Cells as Cellular Immunotherapy

Anticancer research

Masafumi Iguchi

Shigeki Yagyu

Kosuke Kambe

Mayumi Higashi

Shigehisa Fumino

...

2023/6/1

piggyBac-transposon-mediated CAR-T cells for the treatment of hematological and solid malignancies

Shigeki Yagyu

Yozo Nakazawa

2023/6

Method for producing cell population containing car-expressing immune cells

2022/8/25

Chimeric antigen receptor-expressing cells targeting alk

2022/8/11

Development of piggyBac transposon-mediated HER2-CAR-T cells for the treatment of solid tumors

Cancer Research

Koichiro Shioya

Tomio Matsumura

Yuta Ohira

Naomi Komatsuzaki

Manaka Shinagawa

...

2022/6/15

PiggyBac Transposon-Mediated CD19 Chimeric Antigen Receptor-T Cells Derived From CD45RA-Positive Peripheral Blood Mononuclear Cells Possess Potent …

Frontiers in Immunology

Masaya Suematsu

Shigeki Yagyu

Nobuyoshi Nagao

Susumu Kubota

Yuto Shimizu

...

2022/1/27

Non-viral inducible caspase 9 mRNA delivery using lipid nanoparticles against breast cancer: An in vitro study

Biochemical and Biophysical Research Communications

Ikumi Nakashima

Shoji Saito

Eiichi Akahoshi

Shigeki Yagyu

Mitsuko Sugano-Ishihara

...

2022/12/20

The histone deacetylase inhibitor OBP‐801 has in vitro/in vivo anti‐neuroblastoma activity

Pediatrics International

Daisuke Kaneda

Tomoko Iehara

Ken Kikuchi

Yohei Sugimoto

Norio Nakagawa

...

2022/1

Development of minimally invasive cancer immunotherapy using anti-disialoganglioside GD2 antibody-producing mesenchymal stem cells for a neuroblastoma mouse model

Pediatric surgery international

Kosuke Kambe

Masafumi Iguchi

Mayumi Higashi

Shigeki Yagyu

Shigehisa Fumino

...

2022/12/9

Reduced B7-H3 expression by PAX3-FOXO1 knockdown inhibits cellular motility and promotes myogenic differentiation in alveolar rhabdomyosarcoma

Scientific Reports

Takuyo Kanayama

Mitsuru Miyachi

Yohei Sugimoto

Shigeki Yagyu

Ken Kikuchi

...

2021/9/22

Infantile mediastinal neuroblastoma presenting as an oncologic emergency: usefulness of serum-based MYCN gene amplification analysis for risk stratification

BMJ Case Reports CP

Masaya Suematsu

Shigeki Yagyu

Hajime Hosoi

Tomoko Iehara

2021/12/1

Autologous antigen-presenting cells efficiently expand piggyBac transposon CAR-T cells with predominant memory phenotype

Molecular Therapy-Methods & Clinical Development

Kayoko Nakamura

Shigeki Yagyu

Shogo Hirota

Akimasa Tomida

Makoto Kondo

...

2021/6/11

Piggybac Transposon Mediated CD19 CAR-T Cells Derived from CD45RA-Positive PBMCs Possess Potent and Sustained Antileukemic Function

Blood

Masaya Suematsu

Shigeki Yagyu

Nobuyoshi Nagao

Susumu Kubota

Yuto Shimizu

...

2021/11/23

See List of Professors in Shigeki Yagyu University(Kyoto Prefectural University of Medicine)